Medicine and Dentistry
Cell Transdifferentiation
100%
Beta Cell
85%
Diabetes
76%
Streptozocin
68%
Pancreatic Islet
52%
Glucagon
33%
Programmed Cell Death
28%
Glucagon Like Peptide 1
27%
Diabetes Mellitus
24%
Cell Lineage
23%
Receptor
23%
Hydrocortisone
22%
Exenatide
20%
Cell Proliferation
20%
Diabetic Obesity
20%
Cholecystokinin
20%
Pancreas Polypeptide
19%
Glucagon Like Peptide 1 Receptor
16%
Incretin
16%
Gut
15%
Antidiabetic Activity
14%
Insulin Resistance
13%
Body Weight
13%
Antidiabetic Agent
12%
Food Intake
12%
Gastric Inhibitory Polypeptide
12%
Liraglutide
12%
Dapagliflozin
11%
Sitagliptin
11%
Transgenic Mouse
9%
Drug Therapy
9%
Glucagon-Like Peptide-1 Agonist
9%
Vasopressin V1a Receptor
9%
Vasopressin V1b Receptor
9%
Apelin
9%
Adjuvant Therapy
9%
Gastrin
9%
Ob/Ob Mouse
9%
Oxyntomodulin
9%
Insulin Dependent Diabetes Mellitus
9%
Glucagon Receptor Antagonist
9%
Low Drug Dose
9%
Blood Glucose
9%
Cell Dedifferentiation
9%
Cell Differentiation
8%
Cell Survival
8%
Metabolic Stress
7%
Endocrine Cell
6%
Fat Intake
6%
Transcription Factors
6%
Pharmacology, Toxicology and Pharmaceutical Science
Streptozotocin
46%
Glucagon
37%
Exendin 4
30%
Glucagon-Like Peptide-1
27%
Receptor
21%
Diabetes Mellitus
21%
Tarantula
19%
Diabetic Obesity
19%
Glucagon-Like Peptide 1 Receptor
16%
Petromyzon
16%
Incretin
14%
Neuropeptide Y1 Receptor
14%
Mouse Model
12%
Liraglutide
12%
Gastric Inhibitory Polypeptide
12%
Dapagliflozin
11%
Peptide YY
10%
Antidiabetic Agent
9%
Glucagon Like Peptide 1 Receptor Agonist
9%
Receptor Agonist
9%
Pharmacotherapy
9%
Oxyntomodulin
9%
Cholecystokinin Receptor
9%
Apelin
9%
Glucagon Receptor Antagonist
9%
Neuropeptide
9%
Ob/Ob Mouse
9%
Insulin Dependent Diabetes Mellitus
9%
Pancreas Islet Cell Hyperplasia
9%
Gastrin
9%
Diabetogenesis
9%
Insulin Resistance
9%
Pancreas Polypeptide
9%
Cholecystokinin
9%
Combination Therapy
7%
Carboxamide
6%
Hydrocortisone
5%
Sodium Glucose Cotransporter
5%
Yellow Fluorescent Protein
5%
Insulin Deficiency
5%
Biochemistry, Genetics and Molecular Biology
Transdifferentiation
40%
Streptozotocin
39%
Glucagon
29%
Pancreatic Polypeptide
28%
Neuropeptide
26%
Petromyzon
22%
Peptide YY
20%
Cell Lineage
18%
Programmed Cell Death
16%
Cell Growth
16%
Glucagon-Like Peptide-1
12%
Agonist
12%
Cell Survival
12%
Liraglutide
12%
Gastric Inhibitory Polypeptide
12%
Cholecystokinin
10%
Receptor Antagonist
9%
Glucagon Receptor
9%
Cholecystokinin Receptor
9%
Enteroglucagon
9%
Peptidergic
9%
Ob/Ob Mouse
9%
Cell Function
9%
Glucagon-Like Peptide 1 Receptor
9%
Incretin
9%
Receptor Agonists
9%
Drug Therapy
9%
Low Drug Dose
8%
Insulin Release
8%
Body Weight
7%
Blood Plasma
7%
Glucose Blood Level
6%
Antidiabetic Activity
6%
Cellular Differentiation
5%
Cell Proliferation
5%